ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

PROC Procaps Group SA

2.625
0.00 (0.00%)
26 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Procaps Group SA NASDAQ:PROC NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 2.625 2.42 3.08 0 01:00:00

Procaps Group to Host Webinar on Colombian Pharma Market

02/10/2023 1:00pm

Business Wire


Procaps (NASDAQ:PROC)
Historical Stock Chart


From Jun 2023 to Jun 2024

Click Here for more Procaps Charts.

The Webinar will occur on Tuesday, October 10, 2023 at 10:00 a.m. Eastern Time

Procaps Group (NASDAQ: PROC) (“Procaps”), a leading integrated LatAm healthcare and pharmaceutical services company, announced that it will host a webinar dedicated to the Colombian pharma market and its regulations on October 10th.

The Company will host a webinar at 10:00 a.m. Eastern time with Mariana Sarasti, Director of Pharmaceutical Industry Chamber within the National Business Association of Colombia (ANDI).

Mariana is an economist from The Chicago University, with a specialization in social economics from Universidad de los Andes and a master’s degree in public administration from Harvard University. She has extensive experience in business development and strategy, as well as in project planning and management in the public and private sectors.

To access the webinar, please use the following information:

Date:

Tuesday, October 10, 2023

Time:

10:00 a.m. ET

Webinar Link:

click here

The webinar will be broadcast live and available for replay via the investor relations section of Procaps’ website here.

About Procaps Group

Procaps Group, S.A. (“Procaps”) (NASDAQ: PROC) is a leading developer of pharmaceutical and nutraceutical solutions, medicines, and hospital supplies that reach more than 50 countries in all five continents. Procaps has a direct presence in 13 countries in the Americas and more than 5,500 employees working under a sustainable model. Procaps develops, manufactures, and markets over-the-counter (OTC) pharmaceutical products and prescription pharmaceutical drugs (Rx), nutritional supplements and high-potency clinical solutions.

For more information, visit Procaps’ investor relations website investor.procapsgroup.com.

Investor Contact: Melissa Angelini ir@procapsgroup.com investor.procapsgroup.com

1 Year Procaps Chart

1 Year Procaps Chart

1 Month Procaps Chart

1 Month Procaps Chart